Category Archives: Business News

September 2011 — “CE Mark approval of the HeRO Graft allows us to build upon the already successful commercialization of the HeRO Graft in the U.S.,” said Patrick Wethington, Hemosphere President and CEO.  “Receiving EC and ISO 13485 Certification demonstrates … Continue reading →

June 2011 — The HeRO Graft was chosen from over 140 applicants to be part of Premier’s national program recognizing advances in healthcare and featured at the Innovations Celebration along with 17 other healthcare companies. HeRO Graft was selected by … Continue reading →

May 2011 — Surgeons from Duke University, a HeRO Center of Excellence, presented case experience with the HeRO graft in Istanbul, Turkey at the 7th Congress of Vascular Access Society. The full presentation is available here.

Jim Bullock, President and CEO of Atritech, Inc., joined the Board of Directors at Hemosphere in March 2011. Atritech was recently acquired by Boston Scientific. Mr. Bullock brings over 30 years of professional experience in the medical industry. He was … Continue reading →

Shawn Gage, MD, a PA-C of Vascular Surgery at Duke University Medical Center, received an invitation to present the abstract titled, “Central venous recanalization and subsequent implantation of the Hemodialysis Reliable Outflow (HeRO®) device in catheter dependent patients” at the … Continue reading →

An abstract entitled “Early experience with percutaneous interventions on failing HeRO arteriovenous grafts“ was presented at the Society of Interventional Radiology (SIR) in Chicago, IL, March 30, 2011, by Duke University Medical Center. 50 HeRO graft patients were studied and … Continue reading →

We are pleased and honored to be selected amongst a host of emerging medical device companies to receive the Therapeutic Discovery Project Grant. Over 4,600 companies from 47 states applied for the Treasury Department grant to support innovation in biotechnology and medical … Continue reading →

November 2010 — Two posters were presented at the American Society of Nephrology’s Renal Week in Denver, CO, November 16-21, 2010. The largest post-market dataset available with 6 and 12 month followup was presented by Shawn Gage, Duke University. The … Continue reading →

October 2010 — Controversies in Dialysis Access (CiDA) was held in San Francisco with over 500 attendees. Multiple access surgeons shared their personal experience with colleagues from the podium, in case study reviews, and poster presentations.

June 2010 – Patrick Wethington has joined the company as its new CEO, effective immediately.  Wethington brings 18 years of medical device experience and succeeds Doris Engibous.  Press Release

March, 2010 — Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. Kaiser Permanente Ventures, Oakland, Calif., is lead investor, and Mutual Capital Partners, Cleveland, is the second largest new … Continue reading →

March 2010 — Kaiser Permanente Ventures, the media-shy VC arm of Oakland-based Kasier Permanente, was the lead investor in a $9.3 million financing round announced Wednesday by Hemosphere Inc., a private medical device company. See article here

March 2010 — Hemosphere, Inc., has raised more than $9.3 million in equity for its vascular access device that’s used by patients undergoing dialysis, according to a filing with the Securities and Exchange Commission.  Read More

February 2010 — Drs. James Lin, George Nassar, and John Ross shared their clinical experiences at ASDIN in Orlando, FL in mid-February. Dr. Lin shared his experience referring a failing fistula to a HeRO access surgeon resulting in fistula salvage … Continue reading →